Biomarker Development Strategies

Complete the form below to unlock access to ALL audio articles.
ExL Pharma have announced that their Biomarker Development Strategies conference will be held at the Omni Shoreham Hotel in
Washington, DC, January 29-30, 2007
EVENT HIGHLIGHTS
• Hear directly from the FDA about the new regulatory framework for biomarkers
• Hear case studies and real world examples from Novartis, Eli Lilly, Amgen, Bristol Myer
Squibb, Centocor/J&J, Wyeth and National Cancer Institute
• Discover the Role of Collaborations & Consortia in Biomarker advancement
• Advances in the use of Proteomics, Metabolomics and Nanotechnology for Biomarker-
Based Drug Development
• Applications of Biomarkers in Early Phase Studies
• Using Biomarkers for Oncology Clinical Development
Faculty includes:
Alfred Ajami, CSO, Xanthus Pharmceuticals
Felix Frueh, Associate Director Genomics, FDA
Michael Shi, Director of Biomarker Development, Novartis
Register Today! Call 866-207-6529 or visit us at www.exlpharma.com